Medtronic (MDT) 10-K Summary — Year Ended Apr 25, 2025
Medtronic plc filed its annual report for the period ended in late April 2025. The filing describes the company's business, risk factors, financial condition, and liquidity position.
Key takeaway
Year ended Apr 25, 2025 · FY2026 10-K
Medtronic plc filed its annual report for the period ended in late April 2025. The filing describes the company's business, risk factors, financial condition, and liquidity position.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$33.5B
Revenue reported for the fiscal year.
Operating income
$6B
Income from operations reported for the year.
Net income
$4.7B
Net income reported for the year.
Operating cash flow
$7B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Apr 29, 2022 | $31.7B | n/a |
| Apr 28, 2023 | $31.2B | -1.4% |
| Apr 26, 2024 | $32.4B | +3.6% |
| Apr 25, 2025 | $33.5B | +3.6% |
Business overview
Medtronic is a global medical technology company organized under Irish law. The filing indicates the company operates through segments focused on various therapeutic areas, though specific segment details are not provided in the supplied context.
Financial performance
Revenue increased compared to the prior year, while operating income and net income were reported at levels consistent with the revenue growth. Operating cash flow also rose, driven by higher cash collections from customers due to increased sales.
Material risks
The filing includes a cautionary note regarding forward-looking statements, indicating that actual results may differ from projections. The risk factors section is referenced but not detailed in the supplied context, so no specific risks can be identified beyond the general caution.
Liquidity and capital
The company states it is in a strong financial position with balance sheet flexibility. Capital allocation priorities include funding operations, research and development, property and equipment, returning value to shareholders through dividends and share repurchases, satisfying debt maturities, and acquiring businesses and technology.
What to watch
Monitor the trend in revenue growth and operating cash flow generation in the next filing to assess whether the company can sustain its current financial trajectory.